Sept 13 (Reuters) - Bavarian Nordic A/S :
* Said on Monday its partner, Janssen had completed submission for Emergency Use Assessment and Listing (EUAL) for its Ebola vaccine regimen to World Health Organization
* EUAL is special procedure that can be implemented when there is outbreak of disease with high rates of morbidity or mortality and lack of treatment or prevention options
* Said preparations also underway to initiate first-in-human study for multivalent vaccine regimen to combat Ebola, Sudan and Marburg viruses
* Janssen’s investigational preventive Ebola prime-boost vaccine regimen includes Bavarian Nordic’s MVA-BN Filo vaccine
Source text for Eikon:
Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.